Evidence map›Paper›PMID 34023335›Full record

ArticleNeuropharmacology2021

BK channel-forming slo1 proteins mediate the brain artery constriction evoked by the neurosteroid pregnenolone.

Kelsey C North, Anna N Bukiya, Alex M Dopico

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Progesterone activation of βNature communications · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kelsey C NorthDepartment of Pharmacology, Addiction Science and Toxicology, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, 38103, USA.
Anna N BukiyaDepartment of Pharmacology, Addiction Science and Toxicology, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, 38103, USA.
Alex M DopicoDepartment of Pharmacology, Addiction Science and Toxicology, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, 38103, USA. Electronic address: adopico@uthsc.edu.
University of Tennessee Health Science Center · US

Funding

Ethanol actions on slo channels from arteries vs. brainR37AA011560 · NIAAA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI DOPICO, ALEX M. · 2009 to 2018
$3.6M
Regulation of arterial diameter through specific sensing of endogenous steroids and novel nonsteroidal analogs by BK channel subunitsR01HL147315 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI DOPICO, ALEX M. · 2019 to 2022
$2.4M
Cholesterol regulation of smooth muscle BK channel proteins and consequent control of cerebral artery diameterR01HL148941 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BUKIYA, ANNA, DOPICO, ALEX M. · 2020 to 2023
$2.4M
Pregnenolone constricts cerebral vascular arteries through the direct modulation of BK ion channelsF31HL156290 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI NORTH, KELSEY CLELAND · 2021 to 2022
$67k
NHLBI NIH HHS F31 HL156290NHLBI NIH HHS R01 HL147315NHLBI NIH HHS R01 HL148941NIAAA NIH HHS R37 AA011560
6 · The paper itself

Abstract

Pregnenolone is a neurosteroid that modulates glial growth and differentiation, neuronal firing, and several brain functions, these effects being attributed to pregnenolone actions on the neurons and glial cells themselves. Despite the vital role of the cerebral circulation for brain function and the fact that pregnenolone is a vasoactive agent, pregnenolone action on brain arteries remain unknown. Here, we obtained in vivo concentration response curves to pregnenolone on middle cerebral artery (MCA) diameter in anesthetized male and female C57BL/6J mice. In both male and female animals, pregnenolone (1 nM-100 μM) constricted MCA in a concentration-dependent manner, its maximal effect reaching ~22-35% decrease in diameter. Pregnenolone action was replicated in intact and de-endothelialized, in vitro pressurized MCA segments with pregnenolone evoking similar constriction in intact and de-endothelialized MCA. Neurosteroid action was abolished by 1 μM paxilline, a selective blocker of Ca

Indexed as

AnimalsBrainCells, CulturedCerebral ArteriesDose-Response Relationship, DrugFemaleLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsLarge-Conductance Calcium-Activated Potassium ChannelsMaleMiceMice, Inbred C57BLMice, TransgenicNeurosteroidsPregnenoloneVasoconstrictionKcnma1 protein, mouseLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsLarge-Conductance Calcium-Activated Potassium ChannelsNeurosteroidsPregnenoloneBrain arteriesCalcium-activated potassium channelsCerebral artery constrictionNeurosteroidPregnenoloneVoltage-gated potassium channels

Identifiers

PMID34023335
PMCPMC8274572
OpenAlexW3164496680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.